Skip to main content

Intelligent Medicine Acquisition Corp.

IQMDDelisted May 2, 2023
Industry
Blank Checks
SEC CIK
0001850051

Intelligent Medicine Acquisition Corp. was delisted on May 2, 2023; its insiders filed their last Form 4 on Feb 28, 2023; 60 institutions reported holding it in 13F filings for Q4 2022, worth $197.2M in total; superinvestors Starboard Value and Oaktree Capital held it.

Q3 2022 vs. Q2 2022

How the institutions holding Intelligent Medicine Acquisition Corp. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of IQMD: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders58580
Shares15.6M16.1M+450.3K (+2.9%)
Value$156.3M$161.7M+$5.34M (+3.4%)

New holders (7)

Institutions that held Intelligent Medicine Acquisition Corp. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to IQMD in Q3 2022
InstitutionSharesValue% of portfolio
Basso Capital Management, L.P.55,288$557.0K0.13%
Bank of Montreal21,717$219.0K0.00%
Parallax Volatility Advisers, L.P.14,333$144.0K0.00%
Elequin Capital LP1,400$14.0K0.01%
Allworth Financial LP200$2.00K0.00%
Global Trust Asset Management, LLC200$2.00K0.00%
Clear Street LLC120$1.00K0.00%

Sold out (7)

Institutions that held Intelligent Medicine Acquisition Corp. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of IQMD in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Cantor Fitzgerald, L. P.400,000$4.01M
JPMorgan Chase & Co100,000$1.00M
Eisler Capital (UK) Ltd.80,145$803.0K
Omni Event Management Ltd42,018$421.0K
Woodline Partners LP28,650$287.0K
Union Square Park Capital Management, LLC10,000$100.0K
Tower Research Capital LLC (TRC)742$7.00K